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A comprehensive description of the contributions ofAverill A. Liebow to thefield
of pulmonary pathology would be a monumental task. In preparation forwritingthis
addendum to Dr. Lindskog's tribute to Dr. Liebow, the comments and reflections of
former students and colleagues were sought to appreciate the flavor of the man, the
personality, and the drive which led to so productive a career. A montage of the
complete academician-pathologist, teacher, investigator-was assembled. This
essay can outline only in part the directions of his research and his far-reaching
insight, in Dr. Liebow's words, into the"labyrinths ofthe lungs." However, it is more
likely that his greatest contributions can not be measured by any yardstick. Only in
passing will we remind the reader that first and foremost Dr. Liebow was held in
highest esteem as a dedicated instructor of the art and science of medicine and
perhaps, on an even higher plane, as an educator with vision and wisdom.
Dr. Liebow was an adamant proponent of the educational philosophy of the
school of Welch and Winternitz. He steadfastly held in oration and print that
physicians require "education," not "training," and that the basis of education is
opportunity. Opportunity for Dr. Liebow included a concatenation oftimefor study
and self-reflection, time for growth, for physicians parallel growth in both clinical
and investigative skills, time for growth as a humanist, and perhaps most important,
an appreciation that the bases of the finest foundations of education are hard-work,
self-reliance, and self-education.' Therefore, it is not surprising that the career and
teachings of Dr. Liebow were profoundly influential in shaping the clay from which
future medical academicians and physicians emerged. His particular interest was the
lung, but his vast knowledge ofthis subject was only thetip ofthe intellectual iceberg.
While he specifically stimulated countless chest physicians, surgeons, and patholo-
gists with particular interest in diseases of the lung, his competence across the entire
discipline of pathology and endless quest for excellence influenced many students,
residents, and colleagues to continue in the academic practice ofmedicine. "Seek lux
et veritas," an oft-spoken phrase in Dr. Liebow's addresses, reflected not only his
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fondness for his years in New Haven, but also his philosophy of preparation for a
career in medicine.
William Thurlbeck, in the preface to a recent monograph on lung disease published
by the International Academy of Pathology,2 dedicated the volume to the memory of
Dr. Liebow and acknowledged him as one of the founding fathers of modern
pulmonary pathology. Dr. Lindskog has recounted for us the stages of development
of Dr. Liebow's career and the ultimate honors accorded him. But how did he come
to shape the future and direction of pulmonary pathology? What new truths were
made self-evident? And what legacies for the future were left to those choosing to
investigate pulmonary diseases?
Dr. Liebow was himself a superb anatomist and was quick to impress upon
students that, among the three basic pre-clinical disciplines, anatomy was the most
fundamental. To pathology residents, he emphasized that knowledge oftissues under
the microscope was paramount. Only by recognizing the normal could one appreciate
the abnormal. It has been said that no one in his time surpassed Dr. Liebow in his
ability to extract clues to the nature of disease from observations of tissue through
the microscope or at the gross autopsy table. Pure anatomical studies are sprinkled
liberally among his writings in medicine, often sparking innovative physiological
studies or leading to important correlations in diseased states. The basis of many of
his early observations was the plastic cast of the human or canine tracheobronchial
tree and its vascular supply. This methodology, which was modified after the work of
previous investigators and adapted for studies in his laboratory, provided a perma-
nent specimen which could be measured, photographed, or even colorfully painted if
the requirement was to delineate the bronchopulmonary segments. An important
innovation was that the viscosity of the injection mass could be altered so that small
air sacs and minute vessels could be filled, structures that would ordinarily be poorly
seen or obliterated by dissection. Furthermore, by adding pigments to the plastic the
various limbs ofthe pulmonary vascular tree could be selectively highlighted to reveal
anastomoses, hypertrophy, or absence of vessels. This provided important informa-
tion regarding the course of blood flow.
With time, hundreds of casts of both normal and abnormal lungs were studied and
numerous reports emerged. Dr. Lindskog has previously referred to the monograph,
Surgical Anatomy ofthe Bronchovascular Segments, authored with Doctors Hales
and Bloomer [1]. Destructive inflammatory parenchymal lung disease was common
in that day and preservation of functional or uninvolved lung tissue a common goal
among surgeons. The elegant atlas of surgical anatomy of the lung facilitated the
meticulous dissections necessary for conservation of pulmonary tissue. Too mod-
estly, Dr. Lindskog skirts his own remarkable achievements. Enhanced definition of
lung anatomy provided by lung casting enabled Dr. Lindskog to devise new
procedures in those frontier days of thoracic surgery. The practicality of combined
right lower and middle lobe resection through the bronchus intermedius was
recognized, performed, and championed as a result of studying detailed casts of lung
hilum anatomy [2]. The casts were also highly suitable for defining the anatomy of
the collateral circulation to the lungs under experimental conditions, and more
completely describing the normal bronchial circulation. The anatomy of the bron-
chial veins was graphically recorded from the data collected from one hundred forty
casts of human and dog lungs. A later publication detailed patterns of origin and
2Dr. Thurlbeck underscores Dr. Liebow's contribution to our understanding of disease in the living
patient. See The Lung. Edited by W. Thurlbeck, M. Abell. Baltimore, The Williams and Wilkins
Company, 1978.
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distribution of the bronchial arteries [3]. Nascent pediatric cardiologists and cardio-
vascular surgeons were aided in the recognition of congenital thoracic visceral
abnormalities and the planning of therapeutic procedures. Multiple studies describ-
ing patients with anomalous pulmonary venous return and associated lung and other
visceral anomalies resulted from the casting techniques.
New Haven after World War II was a center rich in material for the study of lung
disease. The combined thoracic surgical services of the New Haven Hospital, Laurel
Heights, and Gaylord Hospital flourished under the direction of Dr. Lindskog.
Specimens of tuberculosis, bronchiectasis, and lung abscess, as well as neoplasia,
provided the surgeon and pathologist alike with the raw material from which
emerged clinical advances and stimulated laboratory research. The fruitful collabora-
tions between the departments of thoracic surgery and pathology at Yale secured
generous support from the Office ofNaval Research for the establishment of research
laboratories in cardiopulmonary disease. A measure of the stature and ultimate
impact of this group on the field of pulmonary pathology is the impressive cadre of
trainees who came to the New Haven laboratory. Positions in Dr. Liebow's
laboratory were eagerly sought and filled with promising research fellows from
institutions across the country and from many foreign schools. Observations derived
from the abundance of diseased human tissue suggested directions for investigation
in the laboratory.
The bronchial arterial circulation became a major focus for study during this
period. Bronchial artery casting techniques, modified and refined by Dr. Liebow and
his colleagues, demonstrated the importance of the dual circulation in the lung,
particularly in inflammatory diseases of the airways. It was demonstrated, for
example, that in bronchiectasis the bronchial arteries become hypertrophied and
proliferate in the walls of bronchiectatic sacs [4]. Precapillary anastomoses between
bronchial and pulmonary arterial circulations become functional and it is probable
that new anastomotic channels are established between the two circulations distally
within zones of inflammation. Salutary effects of this protective mechanism include
the revascularization of lung with a diminishing capillary bed and the shunting of
blood away from diseased parenchyma to a more favorable lung environment. An
unfortunate experiment of nature, congenital pulmonary stenosis, produces a similar
effect on the pulmonary collateral circulation. Casts prepared from patients with
tetralogy of Fallot revealed an extensive mediastinal plexus of greatly enlarged
bronchial arteries which extend into the lung to anastomose with the pulnonary
arterial circulation. Ligation ofthe pulmonary artery of dogs provided the laboratory
with a similar experimental model, upon which detailed physiological experiments
and anatomic studies could be performed [5].
Experiments concerned with the collateral circulation of the lung were to become
the principal investigative thrust of Dr. Liebow's laboratory. This reflected his
philosophy that it was insufficient to recognize alterations in structure alone. Instead,
the interrelationship of structure and function must be relentlessly pursued. The
canine model behaved as nature's human experiments had suggested. Significant
collateral flow to lungs with ligated pulmonary arteries developed via the bronchial
arterial circulation. Furthermore, following ligation of the pulmonary vein, the
bronchial venous circulation responded in like fashion. Correlative physiological
experiments showed that with time blood flow increases to the deprived lung, and
this is accompanied by an increase in functional capacity, as measured by gas
exchange. This suggested to Dr. Liebow that a greatly expanded bronchial arterial
and collateral venous circulation might return sufficient oxygenated blood to
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systemic veins to be effective therapy for transposition of the great vessels. This
model of an autogenous oxygenator was successfully created in the laboratory [6].
The ideas of Vineberg and others suggested to Dr. Liebow that cardiac revasculari-
zation utilizing the expanded bronchial circulation might be feasible. Experiments in
the dog established that the collateral circulation to the heart is enhanced following
ligation of a pulmonary artery and creating adhesions between the lung and heart
[7,8]. These experiments, performed in the mid to late 1950s, raised fundamental
questions which were asked then and which persist today. What made the blood
vessels grow, and why was the growth orderly so that the circulations were not
hopelessly intermixed? Preliminary experiments were begun in the laboratory to test
the influence of hormones on blood vessel growth. These same issues are being
addressed in today's most technically sophisticated laboratories.
Dr. Liebow's interest in and fascination with many aspects of the pulmonary
circulation continued throughout his career. The physiology of hypervolemic and
neurogenic pulnionary edema was studied in his laboratory. He described important
aspects of vascular pathology in pulmonary emphysema, notably the expansion of
the bronchial venous collateral circulation [9]. Experimental pulmonary arterial
hypertension (aorta to pulmonary artery shunt) and effects of hyperkinesis (total
pulmonary flow diverted to one lung) were shown to be reliable models for human
pulmonary hypertension. These interests and acknowledged expertise culminated in
several major reviews on pulmonary hypertension and a chapter in S.E. Gould's text,
Pathology of the Heart, a treatise written with Dr. S.E. Downing, largely dealing
with the pathology of the pulmonary vasculature [10,11].
With publication in 1952 of the Armed Forces Institute of Pathology fascicle,
Tumors of the Lower Respiratory Tract [12], Averill Liebow, then Associate
Professor of Pathology at Yale, became widely recognized as an authority on surgical
lesions of the lung. AFIP-sponsored monographs became the bible of practicing
pathologists, offering comprehensive descriptions of both common and rare lesions.
A major portion of this volume was devoted to bronchogenic carcinoma. Dr. Liebow
wrote, "For convenience, malignant epithelial bronchogenic tumorsIof the lung will
be classified on the simplest possible histologic basis: (1) Epidermoid carcinoma, (2)
Anaplastic carcinoma, (3) Adenocarcinoma, (4) Mixed forms ... of the preceding
cell types." This classification (with histological subtypes added, but basically
unchanged) appeared in the World Health Organization monograph on lung cancer
(1969) to which Dr. Liebow was a major contributor. He did not approach the
subject of lung cancer from a purely anatomic viewpoint, but was acutely interested
in the biological interface between benign, proliferative, atypical proliferative, and
neoplastic lesions. He was particularly careful to indicate the known biology of
lesions which histologically simulated cancer, and meticulous in the choice of
illustrative photographs and description of the distinguishing cellular features. A
portion ofthe fascicle emphasized the pitfalls ofdifferentialdiagnosis in the relatively
new field of diagnostic pulmonary cytology. The "malignant" features of benign
reactive mesothelial cells in pleural fluid and mononuclear and epithelial cells from
lung were detailed and contrasted with actual neoplasia. He seemed to be telling us to
tread lightly and circumspectly until we reached firmer ground. Tumors ofthe Lower
Respiratory Tract included discussions of common benign lung tumors, benign and
malignant pleural tumors, non-neoplastic lung tumors such as arteriovenous malfor-
mations (again the utility of the casting technique is so well illustrated), and
involvement of lung by extrathoracic malignancies. Nearly two hundred fifty figures
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illustrate this work and the great majority came from Dr. Liebow's personal
collection.
Students of pulmonary neoplasia recognize as classics two additional papers by
Dr. Liebow. In 1960 a review of the subject of broncho-alveolar carcinoma was
published in Advances in Internal Medicine [13]. This still-controversial lesion was
there better defined, and much of the confusion surrounding previous nomenclature
eliminated by this study. The discussion of the pathology, histogenesis, and natural
history of this pulmonary carcinoma remains definitive today. In 1965, Dr. Edward
Meyer and Dr. Liebow pointed out the distinct association between peripheral
scarring of the lung, atypical epithelial proliferation, and the development of lung
carcinoma [14]. The important analogy was drawn between the sequence ofmetapla-
sia, carcinoma in situ, and carcinoma in the large bronchi previously described by
Auerbach, and peripheral lung injury as a substrate upon which carcinogens might
act.
A word about Dr. Liebow's contributions to the field of exfoliative cytology is
indicated. In his hospital practice inNew Haven, Dr. Liebow devoted much time and
energy to the cytology ofbodyfluids and exfoliated tissue cells. He seemed fascinated
by the challenge to define the events going on internally as reflected in the "flotsam
andjetsam" of body secretions. Most days in the cytology laboratory began with Dr.
Liebow holding court among pathology residents and cytotechnologists. Emphasis
was placed on the accurate definition of all findings: benign, atypical, or malignant.
Identification of non-cellular clues to the nature of the disease and identification of
artifacts were additional objectives. While growing in this field, Dr. Liebow insisted
upon close contact with the referring physicians for those clinical details which
might shade an interpretation. Only on weekends, when the lab was quiet, was there
time for self-education and study by correlating the cytological findings with the
histology provided by tissue biopsy. Dr. Liebow transmitted to residents and fellows
who learned cytology with him not only his enthusiasm and expertise, but his
essentially cautious approach to the field. In one publication Dr. Liebow lamented
the shortcomings of work ofthe previous decadewhichwere self-fulfilling prophesies
of diagnosing cancer cytologically in patients highly suspect of cancer-"a diagnosis
of carcinoma based on examination of the sputum is likely to be correct even ifthe
conclusion is wrongly drawn on the basis offinding metaplastic or other noncancer-
ous epithelium." Thus the stage was set for thescrutiny intheNew Haven Hospital of
large numbers of control patients ". . . in whom the possibility of a carcinoma is
remote." The objective was to delineate the normal and variations of normal before
conclusions about the abnormal were reached. He went on to report percentages of
correct and false positive diagnoses in that series. This remains one ofthe earliest and
best studies in the literature describing the risk of correct interpretation versus error
in cytological examination of bronchial secretions [15].
Dr. Liebow in time became the foremost consultant in lung pathology in the
United States. This had a salubrious effect upon our understanding of pulmonary
reactions to injury. Unequaled as a morphologist and with incisive understanding of
disease mechanisms, he could now begin to categorize and classify pulmonary
disorders based on similarities of anatomical changes and clinical features. Lung
biopsy techniques improved, more patients were studied histologically at a much
earlier time in the clinical course of disease, and records of relatively uncommon
conditions were accumulating at a more rapid rate in the files of consultants. Dr.
Liebow's publications, based on his incomparable collection ofreferred material, are
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a compendium of the natural history of many pulmonary disorders. Indeed, several
of his descriptive analyses represent the original definition of previously unrecog-
nized conditions. Examples include pulmonary alveolar proteinosis, desquamative
interstitial pneumonia, and bronchocentric granulomatosis [16,17,18]. Principles of
his detailed analytical stylewhich apply to all ofDr. Liebow's studies might be drawn
from the proteinosis paper. Twenty-seven cases of a process in which ". . . the
histologic structure of the lesions . . . is so characteristic and similar from one case to
another" had accumulated in the files ofthe Armed Forces Institute ofPathology, the
Massachusetts General Hospital, and the New Haven Hospital. They were reported
in 1958 in collaboration with Drs. Rosen and Castleman as "Pulmonary alveolar
proteinosis, a new entity." In addition to complete clinical and radiographic
summaries of those patients and the profusion of excellent illustrative material to
amplify the text of the anatomical changes, data from clinical investigative ap-
proaches such as histochemistry and biochemical and spectrographic analysis was
included. The authors speculated concerning the pathogenesis of the disorder by
comparing anatomic and radiographic "look-alikes," by considering the probable
histogenesis of the lesions, and by attention to the exposure and occupational
histories of patients. As knowledge ofthis still incompletely understood disorder has
accumulated over the past two decades, largely through the development of success-
ful laboratory models of the disease, we now realize how remarkably accurate those
earlier speculations were. As Dr. Liebow suggested, alveolar proteinosis involves
diffuse injury to alveolar pneumocytes, and many cases are triggered by exposure to
toxic environmental agents.
Many other examples of definitive works emerged from the consultation practice
of Averill Liebow-desquamative interstitial pneumonia (with Drs. Steer and
Billingsley), bronchocentric granulomatosis and the relationship of that entity to
allergic bronchopulmonary aspergillosis (with Drs. Katzenstein and Friedman), and
bronchiolitis obliterans (with Drs. Gosink and Friedman) [19], to name a few. In
collaboration with Charles Carrington came important treatments of the subjects of
eosinophilic pneumonias [20], limited forms of Wegener's granulomatosis [21],
diffuse pulmonary lymphoreticular infiltrates (lymphocytic interstitial pneumonia)
[22], and atypical pulmonarylymphoreticular infiltrates (lymphomatoid granulomat-
osis) [23]. Each of these studies represents a scholarly exercise in descriptive
morphological analysis and would stand alone as a classic in this regard. However,
the papers are more far-reaching because suggestions for future study are virtually
always proferred. Anatomical and clinical data are distilled to extract the pathoge-
netic mechanisms of disease; references to experimental pathology help in further
defining the nature ofthe processes; pointing out features which suggest immunologi-
cal, infectious, or toxic injury to lung provides guidance for investigative work to
follow.
We always were cautioned by Dr. Liebow that the lung, although a complex organ,
can only react to injury in a limited number of ways and that there was likely to be
great difficulty ahead in sorting out the various agents and vectors ofdisease. Similar
histological responses did not necessarily imply a common etiological insult. Thus
bronchiolitis obliterans, which resulted in an obstructing lesion ofsmall airways with
polypoid granulation tissue proliferating within the lumen, might be the sequela of
viral inflammation or inhalation of noxious fumes such as chlorine gas. We were
taught that meticulous scrutiny of tissue for anatomical clues placed in overall
context of tissue responses to injury was a useful clinical and investigative approach
to the discipline of anatomic pathology.
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We have briefly given an overview, by no means complete, of Averill Liebow's
contribution to the field of lung pathology. His interest in pulmonary tumors
continued unabated throughout his career. His papers on pseudotumors, peripheral
carcinoid tumors, chemodectomas, benign clear-cell tumors, and lymphoangiomyo-
matosis of lung underscore that interest. In collaboration with investigators at the
submarine base in Groton, Connecticut, he reported observations on pulmonary
interstitial emphysema and air embolism incurred during decompression. Abnormal
muscular proliferation in lung, structural changes in ageing lungs, the nature of the
Kultschitzky cell-each received his consideration. Contributions to textbooks and
monographs were considerable and have largely been covered in Dr. Lindskog's
tribute and in the preceeding paragraphs. There were others.
Legacies in medicine are not necessarily left by discoveries, books, chapters, or an
extended bibliography. Dr. Liebow's formal publications achieve all of that, and in
total comprise a voluminous, unique, and distinct contribution to the field of lung
pathology. So how do we measure this man's gift to us as compared to those ofother
great scientists, teachers, and physicians? I prefer to state simply that above all he was
an exemplary scholar in two aspects of his career. First, truth was of the essence, he
consistently admonished students and colleagues to seek the truth through investiga-
tion and discovery; truth was a by-product of self-education and application of the
scientific method. Second, he left in his wake evidence that the seeds of his quest for
truth were broadcast widely and fell on fertile soil, to be perpetuated. In a recent
appreciation Dr. Colin Bloor emphasizes the number of former students of Dr.
Liebow who now occupy positions in academic medicine, not only in pulmonary
disease, but in many disciplines, adding, "he was quick to support the good man and
good idea."3
On a personal note, I recall that on June 30, 1973, in La Jolla, on the stroke of
midnight he spontaneously proposed a toast observing the appointment of a new
assistant professor to the faculty of the Yale Department of Pathology. This, Dr.
Liebow viewed as high honor and achievement. For that gesture, for subsequent
support and encouragement, and for giving us the many building blocks, not the least
ofwhich is truth, to build careers in academic medicine, I, we thank Averill Liebow.
31n the American Journal ofPathology, Volume 92, September 1978.
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